Volatile Anesthetic Agents

Volatile anesthetic agents are halogenated compounds delivered as vapors in the inspired gas to produce and maintain general anesthesia. Their effect is governed by the partial pressure they reach in the brain, allowing depth to be titrated breath by breath, and their potency is summarized by the minimum alveolar concentration (MAC) at which half of patients no longer move to a standard surgical stimulus.

Definition

Volatile anesthetic agents are halogenated hydrocarbon or ether compounds administered as inhaled vapors to induce and maintain general anesthesia, with anesthetic effect determined by their partial pressure in the central nervous system and potency expressed as minimum alveolar concentration.

Scope

The topic covers the pharmacology of inhaled volatile agents as a class: how they are delivered and eliminated through the lungs, how potency is quantified by MAC, and how their uptake characteristics shape the speed of onset and recovery. It frames volatile agents as one of the two main approaches to anesthetic maintenance and contrasts them with total intravenous anesthesia. It is a reference overview, not dosing guidance.

Core questions

• How does minimum alveolar concentration (MAC) quantify the potency of a volatile agent?
• What physical properties determine how quickly a volatile agent produces and reverses anesthesia?
• How does maintenance with a volatile agent differ from total intravenous anesthesia?
• How is the brain effect of volatile agents reflected in the electroencephalogram?

Key concepts

• Minimum alveolar concentration (MAC)
• Blood-gas partition coefficient
• Pulmonary uptake and elimination
• Vaporizer-delivered maintenance
• End-tidal anesthetic concentration monitoring
• Volatile-induced EEG patterns
• Postoperative nausea and vomiting association

Mechanisms

Volatile agents are taken up across the alveolar membrane, distributed to the brain, and exert anesthetic effect in proportion to the partial pressure they achieve there; because they are eliminated largely unchanged through the lungs, depth can be raised or lowered by adjusting the inspired concentration. Their potency is indexed by minimum alveolar concentration, and agents with lower blood solubility equilibrate faster, giving more rapid onset and offset. Like other general anesthetics, they alter thalamocortical and cortical activity in ways visible on the electroencephalogram, and these signatures shift with agent and patient age, as shown for sevoflurane by Purdon and colleagues.

Clinical relevance

Volatile agents are a mainstay of anesthetic maintenance, and the concept of MAC and end-tidal concentration monitoring explains how their depth is controlled and compared across drugs. This entry describes the class for reference and education—how the agents behave and are monitored—rather than recommending a particular agent or concentration for any patient.

Epidemiology

Inhaled volatile agents are associated with a higher incidence of postoperative nausea and vomiting than intravenous maintenance, a difference reflected in consensus risk-reduction guidance; they are also greenhouse gases, which has prompted growing attention to the environmental footprint of inhalational anesthesia.

Evidence & guidelines

Consensus guidelines on postoperative nausea and vomiting identify volatile anesthetic exposure as a modifiable risk factor and inform strategies to reduce it, while monitoring standards require measurement of inspired and end-tidal anesthetic concentrations during maintenance. These documents describe practice at the level of standards rather than individual prescriptions.

History

Diethyl ether and chloroform were the first widely used inhaled anesthetics in the nineteenth century, but their flammability and toxicity drove the search for safer compounds. The introduction of fluorinated agents in the mid-twentieth century, and of the modern halogenated ethers, produced today's volatile agents with more favorable uptake, recovery, and safety profiles, and the concept of minimum alveolar concentration provided a common scale for comparing their potency.

Debates

Volatile maintenance versus total intravenous anesthesia

Whether inhalational or intravenous maintenance offers better recovery, lower nausea, or other outcomes is debated; volatile agents are linked to more postoperative nausea and to environmental concerns, while each approach has practical advantages, and the comparison remains an active question.

Key figures

• Patrick L. Purdon
• Emery N. Brown
• Tong J. Gan

Seminal works

• brown-2010
• purdon-2015

Frequently asked questions

What is minimum alveolar concentration (MAC)?

MAC is a measure of a volatile anesthetic's potency, defined as the alveolar concentration at which half of patients do not move in response to a standard surgical stimulus; it provides a common scale for comparing different inhaled agents.

Why do some patients feel more nauseated after inhalational anesthesia?

Volatile anesthetic agents are associated with a higher risk of postoperative nausea and vomiting than intravenous maintenance, which is why consensus guidelines treat volatile exposure as one of the factors to weigh when planning anti-nausea strategies.